Pharmacovigilance on the turn? Adverse reactions methods in 2012

摘要

The more general collection of data, as I propose, would include the known reactions, which may be easily filtered out, as well as events that may or may not be of significance. Patterns of recurring similar events could flag up the possible need for more careful scrutiny. The added responsibility on the prescribing doctor may also encourage reflection before using a me-too product introduced at the expiry of a drug patent with little or no advantage over the established and less expensive product.